Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Good
|
New words:
accompanyingManagement, acronym, advice, afflicted, Africa, African, aid, Andersen, appeal, appealed, appellate, Arthur, attached, attrition, AutoVac, cancelled, closure, coinsurance, Cooperative, correlate, datedMarch, deferral, desired, dialogue, dissemination, DLO, drafted, Eastern, exceed, exploration, exploring, FDAAA, Fletcher, flu, Francisco, FSP, George, GLOBOCAN, highest, hope, hot, Immunotherapeutic, impossible, insignificant, interact, Intercell, intermediate, landmark, logistical, LP, lt, Ministry, multitude, noncontrolling, nonfinancial, Oncothyreon, OS, overturned, passed, patentee, pathogen, payer, persistently, post, preferential, prognostic, Pvalue, rapid, rapidly, Ratify, raw, recategorized, recurring, redundancy, regional, reinterpreted, remedy, Rencarex, repaid, RFS, sixteen, staffing, Stimulon®adjuvant, stipulation, succeed, supplier, synthesized, taxation, television, temperature, theJournal, tiered, Torisel, traditionally, Trovax, TTP, unaffordable, unchanged, Vaccinogen, wereceived, Wilex, withheld, withholding, Wm, young
Removed:
AACR, abnormal, achievement, acute, addressed, adjusting, administered, advisory, affiliation, Albert, alive, AML, applicant, arrangement, article, ASCO, ASH, assay, atlee, Avant, backed, battery, begin, biology, Biomira, causal, causality, central, Chartered, chronic, CML, Coley, colon, Color, combining, commerce, comprised, computer, consistently, Constant, consultation, content, Cork, Covance, creation, cydex, designate, divestiture, donor, driven, Einstein, exclude, exerting, expediting, favorably, feasibility, feasible, featured, Federation, footage, formally, formulate, founded, frank, French, furniture, GE, genetic, Gleevec, great, GVAX, head, healthcare, Hematology, homology, identity, imatinib, immunologically, imposition, incomplete, incorporate, indefinite, indolent, induced, inflammation, informed, inhibitor, instituting, insufficiently, internationally, Intracel, invalidation, invention, inventory, Ireland, Jonathan, journal, knowledge, landscape, launched, leadership, leaseable, left, lifted, liver, lyme, MA, Mainz, makeup, managerial, master, mesylate, metastasized, methodology, modification, monovalent, Moscow, Munich, myeloma, necrotic, notified, offsetting, OncoVax, oral, ovarian, overhead, package, Pennsylvania, permitting, personalization, peter, ph, Philadelphia, pilot, platform, potency, prevail, prevented, priority, promissory, prostate, purity, ranging, realizability, recommend, recommended, relapsed, rendered, renewal, reorganization, reproducibility, resectable, resection, Reserve, responded, resumed, rolling, rupturing, satisfaction, serve, Squibb, stemming, summarized, surrogate, survived, team, technologically, theory, thornton, timeline, toxicity, transporting, turn, unaudited, undermine, underwent, upfront, usage, user, USPTO, validate, veterinary, work, worsening, wrong, Zambia
Filing tables
Filing exhibits
- 10-K Annual report
- 10.1.5 Form of 2007 Restricted Stock Award Agreement
- 10.4 Form of Indemnification Agreement
- 10.9.6 Sixth Amendment to Lease Agreement
- 10.10 Consent to Assignment of Lease Agreement
- 10.11 First Amendment to Consent of Sublease Agreement
- 10.14 Side Letter
- 10.15 Antigenics Consent Agreement
- 10.18.1 Amendment No. 1,2,3,5,6 and 7 to Exclusive License Agreement with Aronex Pharm.
- 10.19 Amended & Restated License Agreement
- 10.28 2004 Executive Incentive Plan
- 23 Consent of KPMG LLP
- 31.1 Certification of CEO Pursuant to Section 302
- 31.2 Certification of CFO Pursuant to Section 302
- 32.1 Certification of CEO & CFO Pursuant to Section 906
Related press release
AGEN similar filings
Filing view
External links
Exhibit 10.4
SCHEDULE TO INDEMNIFICATION AGREEMENT
The following is a list of the current and former directors and executive officers of Antigenics who are party to an Indemnification Agreement, the form of which was filed as Exhibit 10.4 to our registration statement on Form S-1 (File No. 333-91747):
Garo H. Armen, Ph.D.
Noubar Afeyan, Ph.D.
Frank V. AtLee III
Gamil G. de Chadarevian
Brian Corvese
Tom Dechaene
Margaret Eisen
Renu Gupta, MD
John Hatsopoulos
Wadih Jordan
Mark Kessel
Christine Klaskin
Bruce Leicher
Hyam Levitsky, MD
Deanna Petersen
Shalini Sharp
Pramod K. Srivastava, Ph.D.
Peter Thornton
Karen Higgins Valentine
Kerry Wentworth
Alastair Wood, MD
Timothy R. Wright